The House Oversight Subcommittee on Economic and Consumer Policy has sent letters to companies making antibody tests to demand their test data after a Berkeley/UCSF study found that their tests were flawed. The study is looking at more than 100 antibody test kits to determine their effectiveness in identifying people who may be immune to COVID-19. For more on the study, see our press release at Berkeley News. Another story mentioning the Berkeley/UCSF study appeared in U.S. News & World Report, and assistant bioengineering professor Patrick Hsu, an investigator at Berkeley's Innovative Genomics Institute (IGI) who is co-leading the project, discussed the project on CNN Newsroom--link to transcript.